tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

INSM Stock Latest News

Insmed’s Q3 2025 Earnings Highlight Growth and Expansion
Company AnnouncementsInsmed’s Q3 2025 Earnings Highlight Growth and Expansion
2h ago
INSM
Strong Financial Performance and Promising Pipeline Drive Buy Rating for Insmed
PremiumRatings
Strong Financial Performance and Promising Pipeline Drive Buy Rating for Insmed
12h ago
INSM
Insmed’s Strong Financial Performance and Promising Product Launches Reinforce Buy Rating
PremiumRatings
Insmed’s Strong Financial Performance and Promising Product Launches Reinforce Buy Rating
18h ago
INSM
Insmed raises 2025 global Arikayce revenue view to $420M-$430M from $405M-$425M
PremiumThe Fly
Insmed raises 2025 global Arikayce revenue view to $420M-$430M from $405M-$425M
19h ago
INSM
Insmed reports Q3 EPS ($1.75), consensus ($1.37)
PremiumThe Fly
Insmed reports Q3 EPS ($1.75), consensus ($1.37)
19h ago
INSM
Insmed price target raised to $196 from $165 at Mizuho
PremiumThe FlyInsmed price target raised to $196 from $165 at Mizuho
2d ago
INSM
Insmed assumed with an Overweight at Cantor Fitzgerald
Premium
The Fly
Insmed assumed with an Overweight at Cantor Fitzgerald
3d ago
INSM
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
INSM Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
INSM
Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment
PremiumCompany Announcements
Insmed’s CEDAR Study: A Potential Game-Changer for Hidradenitis Suppurativa Treatment
3d ago
INSM
Insmed’s Phase 1 Study on TPIP Formulations: A Potential Game-Changer in Drug Delivery
PremiumCompany Announcements
Insmed’s Phase 1 Study on TPIP Formulations: A Potential Game-Changer in Drug Delivery
3d ago
INSM
Insmed’s New Phase 3 Study: A Potential Game Changer for PH-ILD Treatment?
PremiumCompany Announcements
Insmed’s New Phase 3 Study: A Potential Game Changer for PH-ILD Treatment?
3d ago
INSM
Insmed price target raised to $187 from $142 at BofA
PremiumThe Fly
Insmed price target raised to $187 from $142 at BofA
4d ago
INSM
Promising Market Prospects and Strong Support Drive Buy Rating for Insmed
PremiumRatingsPromising Market Prospects and Strong Support Drive Buy Rating for Insmed
4d ago
INSM
Positive Outlook for Insmed: Promising Product Pipeline and Favorable Market Position Justify Buy Rating
Premium
Ratings
Positive Outlook for Insmed: Promising Product Pipeline and Favorable Market Position Justify Buy Rating
8d ago
INSM
Optimistic Buy Rating for Insmed’s Brinsupri Amid Strong Market Potential and Expansion Opportunities
Premium
Ratings
Optimistic Buy Rating for Insmed’s Brinsupri Amid Strong Market Potential and Expansion Opportunities
11d ago
INSM
Insmed says CHMP recommends EU approval of BRINSUPRI
PremiumThe Fly
Insmed says CHMP recommends EU approval of BRINSUPRI
14d ago
INSM
Insmed price target raised to $194 from $140 at UBS
PremiumThe Fly
Insmed price target raised to $194 from $140 at UBS
17d ago
INSM
Insmed’s Promising Growth Prospects: Buy Rating Driven by Brinsupri’s Blockbuster Potential and Strategic Market Positioning
PremiumRatings
Insmed’s Promising Growth Prospects: Buy Rating Driven by Brinsupri’s Blockbuster Potential and Strategic Market Positioning
17d ago
INSM
Private Markets: AI model startup Reflection AI raises $2B
PremiumThe Fly
Private Markets: AI model startup Reflection AI raises $2B
21d ago
QS
IOT
Insmed price target raised to $193 from $154 at TD Cowen
PremiumThe FlyInsmed price target raised to $193 from $154 at TD Cowen
29d ago
INSM
Insmed’s TPIP Shows Promising Phase 2 Results, Boosting Buy Rating and Future Prospects
Premium
Ratings
Insmed’s TPIP Shows Promising Phase 2 Results, Boosting Buy Rating and Future Prospects
29d ago
INSM
Insmed price target raised to $180 from $110 at Evercore ISI
Premium
The Fly
Insmed price target raised to $180 from $110 at Evercore ISI
30d ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >